ImmunoGen

+$0.42 (+6.28%) As of 3:41 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunoGen and other ETFs, options, and stocks.

About IMGN

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151.

CEO
Mark Joseph Enyedy
Employees
79
Headquarters
Waltham, Massachusetts
Founded
1981

IMGN Key Statistics

Market cap
1.52B
Price-Earnings ratio
—
Dividend yield
—
Average volume
12.88M
High today
$7.11
Low today
$6.79
Open price
$6.79
Volume
370.25K
52 Week high
$10.88
52 Week low
$4.73

IMGN Earnings

-$0.19
-$0.07
$0.04
$0.16
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure